219 - Robust and Consistent Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) Across Different Age Ranges and Frailty Status in Older Adults

Thursday, October 17, 2024

3:30 PM – 3:45 PM US PT

Location: 404 AB

Co-Author(s)

IL

Isabel Leroux-Roels, PhD MD

Head of Department
Ghent University and Ghent University Hospital, Ghent, Belgium
Ghent, Oost-Vlaanderen, Belgium
RF

Robert G. Feldman, MD

Senior Clinical Trials Inc., Laguna Hills, CA, United States
Laguna Hills, California, United States
RA

Raffaele Antonelli-Incalzi, MD

Università Campus Bio-Medico di Roma, Rome, Italy
Rome, Lazio, Italy
DL

Dong-Gun Lee, PhD MD

Professor
The Catholic University of Korea, Seoul, South Korea
Seoul, Seoul-t'ukpyolsi, Republic of Korea
AP

Alberto Papi, MD

Professor of Respiratory Medicine
University of Ferrara, St. Anna University Hospital, Ferrara, Italy
Ferrara, Emilia-Romagna, Italy
Michael G. Ison, MD MS (he/him/his)

Chief, Respiratory Diseases Branch
National Institutes of Health
Derwood, MD, United States
MD

Marie-Pierre David, Master in Statistics

Lead statistician
GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium
CV

Carline Vanden Abeele, MS

GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium
Md

Magali de Heusch, PhD

Expert Scientist
GSK
Wavre, Brabant Wallon, Belgium
ND

Nathalie De Schrevel, PhD

Clinical Readout Team Leader
GSK, Rixensart, Belgium
Rixensart, Brabant Wallon, Belgium
CG

Catherine Gerard, PhD

GSK, Rixensart, Belgium
Rixensart, Brabant Wallon, Belgium
AO

Aurélie Olivier, PhD

GlaxoSmithKline Biologicals
Wavre, Brabant Wallon, Belgium
MV

Marie Van Der Wielen, MD

Doctor
GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium

Presenting Author(s)

Veronica Hulstrøm, MD, PhD (she/her/hers)

Sr Dir. Clinical Project Lead RSV OA
GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium

Slides

Disclosure(s):

Isabel Leroux-Roels, PhD MD: Curevac: Grant/Research Support; GSK: Grant/Research Support; Icosavax: Grant/Research Support; Janseen Vaccines: Advisor/Consultant, Board Member, Grant/Research Support; Moderna: Grant/Research Support; MSD: Advisor/Consultant, Grant/Research Support; OSE Immunotherapeutics: Grant/Research Support; Osivax: Grant/Research Support

Robert G. Feldman, MD: GSK: Payment to attend congress and speaking events, travel expenses for these events

Raffaele Antonelli-Incalzi, MD: GSK: Grant/Research Support

Alberto Papi, MD: Agenzia Italiana del farmaco (AIFA): Grant/Research Support; AstraZeneca: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Avillion: Advisor/Consultant, Board Member, Honoraria; CHIESI: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Edmond Pharma: Advisor/Consultant, Honoraria; Elpen Pharmaceutica: Advisor/Consultant, Board Member, Honoraria; GSK: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; IQVIA: Board Member, Honoraria; Menarini: Honoraria; Mundipharma: Honoraria; Novartis: Advisor/Consultant, Board Member, Honoraria; Sanofi: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Zambon: Advisor/Consultant, Honoraria

Michael G. Ison, MD MS: Adagio: Advisor/Consultant (); Adamis: Advisor/Consultant (), Board Member (); ADMA Biologics: Advisor/Consultant (); AlloVir: Advisor/Consultant (), Board Member (); Cidara: Advisor/Consultant (); CSL Behring: Board Member (); Genentech: Advisor/Consultant (); GSK: Grant/Research Support (); ISIRV AVG: Chair (); Janssen: Advisor/Consultant (), Board Member (); Merck: Board Member (); NIH: Board Member (); Roche: Advisor/Consultant (); Sequiris: Board Member (); Shinogi: Advisor/Consultant (); Takeda: Advisor/Consultant (), Board Member (); Talaris: Advisor/Consultant (), Board Member (); Transplant Infectious Disease: Editor-in-Chief (); UpToDate: Royalties ()

Marie-Pierre David, Master in Statistics: GSK: As GSK employee, I’m part of a patent application, Salary as GSK employee with stock options, Stocks/Bonds (Public Company)

Carline Vanden Abeele, MS: GSK: Salary as GSK employee with stock options, Stocks/Bonds (Public Company)

Magali de Heusch, PhD: GSK: Salary as GSK employee with stock options, Stocks/Bonds (Public Company)

Nathalie De Schrevel, PhD: GSK: Magali De Heusch, Stocks/Bonds (Public Company)

Catherine Gerard, PhD: GSK: Salary as GSK employee with stock options, Stocks/Bonds (Public Company)

Aurélie Olivier, PhD: GSK: As GSK employee, I’m part of a patent application, employee, Stocks/Bonds (Public Company)

Marie Van Der Wielen, MD: GSK: As GSK employee, I’m part of a patent application, Salary as GSK employee with stock options, Stocks/Bonds (Public Company)

Veronica Hulstrøm, MD, PhD: GSK: Salary as GSK employee with stock options, Stocks/Bonds (Public Company)